Intriguingly, miR-146b is also known to down-regulate dystrophin in multiple muscle diseases, is increased in dystrophinopathies and in myositis, and is also drug-responsive in the mdx mouse model of DMD [30,31]. This evidence concerns the gene DMD and neuromuscular disease caused by qualitative or quantitative defects of dystrophin.